次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

ヒトマイクロバイオームの世界市場:2028年に至る技術別、疾患別予測

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) - Global Forecast to 2028

出版元:MarketsandMarketsLinkIcon出版元について
発行年:2021年3月
定価 Single User License(1名様ライセンス)US$4,950(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文172ページになります。
商品コード:MAM2370

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
ヒトマイクロバイオームの世界市場規模は今後市場化が進み、2025年段階では8億9400万ドル、2028年には15億9800万ドルへと急速な拡大が予測されます。
レポートはヒトマイクロバイオームの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。また市場をさまざまな切り口で細分化し、そのセグメント市場ごとの市場予測を中心に構成されています。当レポートでの各種セグメント市場の区分は、製品別市場、疾患別市場、用途別市場、技術別市場および主要国地域別市場、などとなっています。また競合状況、主要企業情報(25社)、COVID-19によるヒトマイクロバイオーム市場への影響、特許分析などの分析情報も加味し、ヒトマイクロバイオーム市場の今後成長性および動向を詳細にレポートしています。

【レポート構成概要】
◆ヒトマイクロバイオームの世界市場予測2019-2028年
・市場規模(US$)

◆製品別、市場-2028年
・医薬品
・診断テスト
・プロバイオティクス
・プレバイオティクス
・その他製品
※(市場規模US$) 

◆疾患別、市場-2028年
・感染症
・胃腸疾患
・内分泌/代謝障害
・がん
・その他疾患
※(市場規模US$) 

◆用途別、市場-2028年
・治療用途
・診断用途
※(市場規模US$) 

◆技術別、市場-2028年
ゲノミクス
・シーケンシング
-16S rRNAシーケンシング
-全ゲノムシーケンス(WGS)
-その他シーケンシング
・その他ゲノミクス技術
プロテオミクス
メタボロミクス
※(市場規模US$) 

◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照
※国別に技術別の細分化データ掲載

◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・COVID-19によるヒトマイクロバイオーム市場への影響
・特許分析
・競合状況

◆ヒトマイクロバイオームの主要企業プロフィール動向
・ENTEROME  
・SERES THERAPEUTICS           
・D PHARMA PLC         
・EVELO BIOSCIENCES, INC.    
・OPTIBIOTIX HEALTH PLC     
・SYNLOGIC    
・SECOND GENOME    
・VEDANTA BIOSCIENCES, INC.             
・FERRING PHARMACEUTICALS           
・VITHERA PHARMACEUTICALS, INC.  
・BIOMX           
・DUPOINT      
・KALEIDO      
・YSOPIA BIOSCIENCE 
・FLIGHTPATH
・FINCH THERAPEUTICS GROUP, INC  
・QUANTBIOME, INC. (DBA THRYVE)  
・VIOME, INC.  
・DAYTWO INC
・BIOHM          
・ATLAS BIOMED GROUP LIMITED.     
・BIONE            
・LUXIA SCIENTIFIC     
・SUN GENOMICS         
・METABIOMICS

 

(全172頁)



【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) - Global Forecast to 2028

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION
1.2.1              INCLUSIONS & EXCLUSIONS
1.3             MARKET SCOPE
1.3.1              MARKETS COVERED FOR THE HUMAN MICROBIOME MARKET
1.3.2              MARKETS COVERED FOR HUMAN MICROBIOME RESEARCH SPENDING MARKET
1.3.3              YEARS COVERED FOR THE STUDY (HUMAN MICROBIOME RESEARCH SPENDING MARKET)
1.3.4              YEARS COVERED FOR THE STUDY (HUMAN MICROBIOME DIAGNOSTIC APPLICATIONS MARKETS)
1.3.5              YEARS COVERED FOR THE STUDY (HUMAN MICROBIOME THERAPEUTIC APPLICATION MARKETS)
1.4             CURRENCY
1.5             STAKEHOLDERS
1.6             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
2.1.1              SECONDARY DATA
2.1.2              PRIMARY SOURCES.. 29
・       FIGURE 1......... BREAKDOWN OF PRIMARIES: HUMAN MICROBIOME MARKET
2.2             MARKET DATA ESTIMATION AND TRIANGULATION
・       FIGURE 2.......................... DATA TRIANGULATION METHODOLOGY
2.2.1              MARKET ESTIMATION METHODOLOGY
・       FIGURE 3..... MARKET SIZE ESTIMATION APPROACH: R&D SPENDING ANALYSIS-BASED ESTIMATION (FOR HUMAN MICROBIOME RESEARCH SPENDING MARKET)
・       FIGURE 4 HUMAN MICROBIOME RESEARCH SPENDING MARKET SIZE (USD MILLION): FINAL MARKET SIZE
2.2.2              GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
・       FIGURE 5....................... FINAL CAGR PROJECTIONS (2020−2025)
2.2.3              POTENTIAL MARKET SIZE CALCULATION FOR HUMAN MICROBIOME MARKET
・       FIGURE 6............... HUMAN MICROBIOME MARKET SIZE BASED ON EPIDEMIOLOGY APPROACH
・       FIGURE 7............... MARKET VALIDATION FROM PRIMARY EXPERTS
2.3             RESEARCH ASSUMPTIONS

3.... EXECUTIVE SUMMARY

・       FIGURE 8.... HUMAN MICROBIOME MARKET, BY PRODUCT, 2025 VS. 2028 (USD MILLION)
・       FIGURE 9.. HUMAN MICROBIOME MARKET SHARE, BY APPLICATION, 2024
・       FIGURE 10.... HUMAN MICROBIOME MARKET, BY DISEASE, 2025 VS. 2028 (USD MILLION)
・       FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE HUMAN MICROBIOME MARKET

4.... PREMIUM INSIGHTS

4.1             HUMAN MICROBIOME: MARKET OVERVIEW
・       FIGURE 12.............. INCREASING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE THE GROWTH OF THIS MARKET
4.2             HUMAN MICROBIOME RESEARCH SPENDING MARKET,  BY TECHNOLOGY (2020 VS. 2025)
・       FIGURE 13....... GENOMIC TECHNOLOGIES DOMINATED THE HUMAN MICROBIOME RESEARCH SPENDING MARKET IN 2020
4.3             NORTH AMERICA: HUMAN MICROBIOME MARKET,  BY PRODUCT & APPLICATION (2024)
4.4             HUMAN MICROBIOME RESEARCH SPENDING MARKET,  BY COUNTRY (2020–2025)
・       FIGURE 14....... CHINA TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 15.. HUMAN MICROBIOME MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1              MARKET DRIVERS
5.2.1.1            INCREASING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT
5.2.1.2            HUMAN MICROBIOME AS A VALIDATED TARGET FOR DRUG DEVELOPMENT
5.2.1.3            DEVELOPMENT OF HUMAN MICROBIOME-BASED TESTS FOR EARLY DISEASE DETECTION & DIAGNOSIS
5.2.2              MARKET OPPORTUNITIES
5.2.2.1            INCREASING COLLABORATIONS BETWEEN PUBLIC-PRIVATE ORGANIZATIONS
5.2.3              MARKET CHALLENGES.. 46
5.2.3.1            GOVERNMENT REGULATIONS
5.2.3.2            LACK OF EXPERTISE AND INADEQUATE RESEARCH
5.2.4              MARKET RESTRAINTS.. 47
5.2.4.1            BARRIERS IN PROVING THE CAUSAL LINK BETWEEN DYSBIOSIS  AND DISEASES
5.3             IMPACT OF THE COVID-19 ON THE MARKET
5.4             TECHNOLOGY ANALYSIS
5.5             REGULATORY ANALYSIS.. 49
5.5.1              FOR HUMAN MICROBIOME-BASED DRUGS CATEGORY
5.5.2              FOR HUMAN MICROBIOME-BASED FOODS CATEGORY
5.6             PATENT ANALYSIS

6.... HUMAN MICROBIOME MARKET, BY PRODUCT

6.1             INTRODUCTION
・       TABLE 1.. HUMAN MICROBIOME MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
6.2             DRUGS
6.2.1              INCREASING NUMBER OF MICROBIOME-BASED DRUGS IN THE PIPELINE IS A KEY FACTOR DRIVING MARKET GROWTH
・       TABLE 2..... HUMAN MICROBIOME MARKET FOR DRUGS, BY REGION, 2022–2028 (USD MILLION)
・       TABLE 3........ NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DRUGS, BY COUNTRY  2022–2028 (USD MILLION)
6.3             DIAGNOSTIC TESTS
6.3.1              GROWING CONSUMER AWARENESS ABOUT MICROBIOME-BASED TESTS TO DRIVE MARKET GROWTH
・       TABLE 4. HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS, BY REGION,  2019–2028 (USD MILLION)
・       TABLE 5........ NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DIAGNOSTIC TESTS, BY COUNTRY 2019–2028 (USD MILLION)
6.4             PROBIOTICS
6.4.1              ONGOING RESEARCH ON PROBIOTICS IS PROMOTING ITS CREDIBILITY IN HEALTH CLAIMS AND SAFETY, THUS DRIVING MARKET GROWTH
・       TABLE 6.......... HUMAN MICROBIOME MARKET FOR PROBIOTICS, BY REGION,  2023–2028 (USD MILLION)
・       TABLE 7........ NORTH AMERICA: HUMAN MICROBIOME MARKET FOR PROBIOTICS, BY COUNTRY,  2019–2028 (USD MILLION)
6.5             PREBIOTICS
6.5.1              DEVELOPMENT OF TARGETED PREBIOTICS IN ENHANCING GUT MICROBIOTA IS THE KEY GROWTH DRIVER FOR THIS SEGMENT
・       TABLE 8.......... HUMAN MICROBIOME MARKET FOR PREBIOTICS, BY REGION,  2023–2028 (USD MILLION)
・       TABLE 9........ NORTH AMERICA: HUMAN MICROBIOME MARKET FOR PREBIOTICS, BY COUNTRY,  2023- 2028 (USD MILLION)
6.6             OTHER PRODUCTS
・       TABLE 10. HUMAN MICROBIOME MARKET FOR OTHER PRODUCTS, BY REGION,  2023–2028 (USD MILLION)
・       TABLE 11...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2023-2028 (USD MILLION)

7.... HUMAN MICROBIOME MARKET, BY DISEASE

7.1             INTRODUCTION
・       TABLE 12.. HUMAN MICROBIOME MARKET, BY DISEASE, 2022–2028 (USD MILLION)
7.2             INFECTIOUS DISEASES
7.2.1              INCREASING NUMBER OF CLINICAL STUDIES FOR CLOSTRIDIUM DIFFICILE INFECTION TO DRIVE MARKET GROWTH
・       TABLE 13....... DEVELOPMENT OF MICROBIOME-BASED DRUGS FOR  INFECTIOUS DISEASES
・       TABLE 14 HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES, BY REGION,  2022–2027 (USD MILLION)
・       TABLE 15...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR INFECTIOUS DISEASES,  BY COUNTRY, 2022–2028 (USD MILLION)
7.3             GASTROINTESTINAL DISEASES
7.3.1              INCREASING NUMBER OF CLINICAL STUDIES FOR GASTROINTESTINAL DISEASES TO DRIVE MARKET GROWTH
・       TABLE 16... HUMAN MICROBIOME MARKET FOR GASTROINTESTINAL DISEASES, BY REGION,  2022–2028 (USD MILLION)
・       TABLE 17...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR GASTROINTESTINAL DISEASES,  BY COUNTRY, 2022–2028 (USD MILLION)
7.4             ENDOCRINE & METABOLIC DISORDERS
7.4.1              THE DEVELOPMENT OF MICROBIOME MODULATORS FOR THE TREATMENT OF METABOLIC DISORDERS DRIVES MARKET GROWTH
・       TABLE 18........... HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS,  BY REGION, 2022-2028 (USD MILLION)
・       TABLE 19...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR ENDOCRINE & METABOLIC DISORDERS, BY COUNTRY, 2022–2028 (USD MILLION)
7.5             CANCER
7.5.1              MICROBIOME-BASED PRODUCTS HAVE DEMONSTRATED EFFICACY IN THE TREATMENT OF PELVIC AND COLON CANCER
・       TABLE 20.. HUMAN MICROBIOME MARKET FOR CANCER, BY REGION,  2022–2028 (USD MILLION)
・       TABLE 21...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR CANCER, BY COUNTRY,  2022–2028 (USD MILLION)
7.6             OTHER DISEASES
・       TABLE 22.. HUMAN MICROBIOME MARKET FOR OTHER DISEASES, BY REGION,  2022–2028 (USD MILLION)
・       TABLE 23...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2028 (USD MILLION). 68

8.... HUMAN MICROBIOME MARKET, BY APPLICATION

8.1             INTRODUCTION
・       TABLE 24... HUMAN MICROBIOME MARKET, BY APPLICATION, 2019–2028 (USD MILLION)
8.2             THERAPEUTIC APPLICATIONS
8.2.1              AVAILABILITY OF FUNDING FOR THE DEVELOPMENT OF MICROBIOME-BASED THERAPEUTIC PRODUCTS TO DRIVE MARKET GROWTH
・       TABLE 25........... HUMAN MICROBIOME MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION,  2019–2028 (USD MILLION)
・       TABLE 26...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR THERAPEUTIC APPLICATIONS,  BY COUNTRY, 2019–2028 (USD MILLION)
8.3             DIAGNOSTIC APPLICATIONS
8.3.1              INCREASING FOCUS ON BIOMARKER-BASED DIAGNOSTIC TESTS TO DRIVE MARKET GROWTH
・       TABLE 27............. HUMAN MICROBIOME MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION,  2019–2028 (USD MILLION)
・       TABLE 28...... NORTH AMERICA: HUMAN MICROBIOME MARKET FOR DIAGNOSTIC APPLICATIONS,  BY COUNTRY, 2019–2028 (USD MILLION)

9.... HUMAN MICROBIOME RESEARCH SPENDING MARKET,  BY TECHNOLOGY

9.1             INTRODUCTION
・       TABLE 29.. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
9.2             GENOMICS
・       TABLE 30 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY TYPE,  2018–2025 (USD MILLION)
・       TABLE 31 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 32......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 33..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS,  BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 34 ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR GENOMICS,  BY COUNTRY, 2018–2025 (USD MILLION)
9.2.1              SEQUENCING
・       TABLE 35 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 36......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 37..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING,  BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 38 ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 39 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR SEQUENCING, BY METHOD, 2018–2025 (USD MILLION)
9.2.1.1            16S RRNA SEQUENCING METHOD
9.2.1.1.1            THIS METHOD IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS
・       TABLE 40 16S RRNA SEQUENCING METHOD, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 41.... NORTH AMERICA: 16S RRNA SEQUENCING METHOD, BY COUNTRY,  2018–2025 (USD MILLION)
・       TABLE 42. EUROPE: 16S RRNA SEQUENCING METHOD, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 43......... ASIA PACIFIC: 16S RRNA SEQUENCING METHOD, BY COUNTRY,  2018–2025 (USD MILLION)
9.2.1.2            WHOLE-GENOME SEQUENCING(WGS)METHOD
9.2.1.2.1            WGS HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION
・       TABLE 44..... WGS METHOD, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 45 NORTH AMERICA: WGS METHOD, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 46... EUROPE: WGS METHOD, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 47.... ASIA PACIFIC: WGS METHOD, BY COUNTRY, 2018–2025 (USD MILLION)
9.2.1.3            OTHER SEQUENCING METHODS
・       TABLE 48.. OTHER SEQUENCING METHODS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 49....... NORTH AMERICA: OTHER SEQUENCING METHODS, BY COUNTRY,  2018–2025 (USD MILLION)
・       TABLE 50.... EUROPE: OTHER SEQUENCING METHODS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 51 ASIA PACIFIC: OTHER SEQUENCING METHODS BY COUNTRY, 2018–2025 (USD MILLION)
9.2.2              OTHER GENOMIC TECHNOLOGIES
・       TABLE 52 HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION). 82
・       TABLE 53......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 54..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 55 ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET FOR OTHER GENOMIC TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)
9.3             PROTEOMICS
9.3.1              TECHNOLOGICAL ADVANCEMENTS IN PROTEOMIC TECHNOLOGIES TO DRIVE MARKET GROWTH
・       TABLE 56...... PROTEOMICS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 57 NORTH AMERICA: PROTEOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 58... EUROPE: PROTEOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 59.... ASIA PACIFIC: PROTEOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
9.4             METABOLOMICS
9.4.1              ADVANTAGES OF METABOLOMICS OVER GENOMICS AND PROTEOMICS IN MICROBIOME RESEARCH TO DRIVE MARKET GROWTH
・       TABLE 60.. METABOLOMICS, BY REGION, 2018–2025 (USD MILLION)
・       TABLE 61... NORTH AMERICA: METABOLOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 62 EUROPE: METABOLOMICS, BY COUNTRY, 2018–2025 (USD MILLION)
・       TABLE 63 ASIA PACIFIC: METABOLOMICS, BY COUNTRY, 2018–2025 (USD MILLION)

10.. HUMAN MICROBIOME MARKET, BY REGION

10.1          INTRODUCTION
・       TABLE 64... HUMAN MICROBIOME MARKET, BY REGION, 2019–2028 (USD MILLION)
・       TABLE 65.. HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY REGION,  2018–2025 (USD MILLION)
10.2          NORTH AMERICA
・       FIGURE 16.......... NORTH AMERICA: HUMAN MICROBIOME MARKET SNAPSHOT
・       TABLE 66........ NORTH AMERICA: HUMAN MICROBIOME MARKET, BY PRODUCT,  2019–2028 (USD MILLION)
・       TABLE 67........ NORTH AMERICA: HUMAN MICROBIOME MARKET, BY APPLICATION,  2019–2028 (USD MILLION)
・       TABLE 68........ NORTH AMERICA: HUMAN MICROBIOME MARKET, BY DISEASE,  2022-2028 (USD MILLION)
・       TABLE 69........ NORTH AMERICA: HUMAN MICROBIOME MARKET, BY COUNTRY,  2019–2025 (USD MILLION)
・       TABLE 70......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
・       TABLE 71......... NORTH AMERICA: HUMAN MICROBIOME RESEARCH SPENDING MARKET,  BY TECHNOLOGY, 2018–2025 (USD MILLION)
・       TABLE 72..... NORTH AMERICA: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 73...... NORTH AMERICA: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.2.1            US
10.2.1.1          INCREASING INVESTMENTS BY NIH IN SUPPORT OF MICROBIOME RESEARCH IS DRIVING THE MARKET GROWTH IN THE US
・       TABLE 74.. US: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
・       TABLE 75....... US: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019–2028 (USD MILLION)
・       TABLE 76.... US: HUMAN MICROBIOME MARKET, BY DISEASE, 2022–2028 (USD MILLION)
・       TABLE 77 US: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 78........ US: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 79 US: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.2.2            CANADA
10.2.2.1          INCREASING GOVERNMENT SUPPORT AND FUNDS SUPPORT MARKET GROWTH FOR MICROBIOME RESEARCH IN CANADA
・       TABLE 80................ INDICATIVE LIST OF PROJECTS ON THE HUMAN MICROBIOME IN 2018
・       TABLE 81.... CANADA: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
・       TABLE 82 CANADA: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019–2028 (USD MILLION)
・       TABLE 83...... CANADA: HUMAN MICROBIOME MARKET, BY DISEASE, 2022-2028 (USD MILLION)
・       TABLE 84..... CANADA: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 85. CANADA: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 86 CANADA: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.3          EUROPE
・       TABLE 87......................................... EU MICROBIOME PROJECT
・       TABLE 88.... EUROPE: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
・       TABLE 89 EUROPE: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019–2028 (USD MILLION)
・       TABLE 90...... EUROPE: HUMAN MICROBIOME MARKET, BY DISEASE, 2022–2028 (USD MILLION)
・       TABLE 91..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
・       TABLE 92..... EUROPE: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 93. EUROPE: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 94 EUROPE: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.3.1            GERMANY
10.3.1.1          EXTENDED APPLICATIONS OF MICROBIOME RESEARCH TO THERAPEUTIC AREAS TO BOOST THE ADOPTION OF MICROBIOME-BASED PRODUCTS IN GERMANY
・       TABLE 95... GERMANY: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 96...... GERMANY: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 97..... GERMANY: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.3.2            UK
10.3.2.1          INCREASING FOCUS ON THE DEVELOPMENT OF MICROBIOME-BASED PRODUCTS IN THE UK TO DRIVE MARKET GROWTH
・       TABLE 98 UK: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 99........ UK: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 100...... UK: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.3.3            FRANCE
10.3.3.1          INCREASING FUNDING TO BOOST THE DEVELOPMENT OF MICROBIOME-BASED PRODUCTS IN EUROPE
・       TABLE 101.... FRANCE: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 102 FRANCE: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 103...... FRANCE: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.3.4            ROE
・       TABLE 104......... ROE: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 105..... ROE: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 106.... ROE: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.4          ASIA PACIFIC
・       FIGURE 17 ASIA PACIFIC: HUMAN MICROBIOME MARKET SNAPSHOT
・       TABLE 107........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
・       TABLE 108........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY APPLICATION,  2019–2028 (USD MILLION)
・       TABLE 109........... ASIA PACIFIC: HUMAN MICROBIOME MARKET, BY DISEASE, 2022–2028 (USD MILLION)
・       TABLE 110............ ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
・       TABLE 111............ ASIA PACIFIC: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 112 ASIA PACIFIC: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 113 ASIA PACIFIC: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.4.1            CHINA
10.4.1.1          A LARGE NUMBER OF HUMAN MICROBIOME RESEARCH STUDIES ARE CONDUCTED IN CHINA, THUS DRIVING MARKET GROWTH
・       TABLE 114..... INDICATIVE LIST OF HUMAN MICROBIOME RESEARCH STUDIES CONDUCTED IN CHINA
・       TABLE 115...... CHINA: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 116........ CHINA: GENOMICS TECHNOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 117. CHINA: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.4.2            JAPAN
10.4.2.1          INCREASING FOCUS ON FUNDING FOR MICROBIOME-BASED PRODUCTS TO DRIVE MARKET GROWTH
・       TABLE 118...... JAPAN: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 119.. JAPAN: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 120. JAPAN: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.4.3            INDIA
10.4.3.1          GOVERNMENT FUNDING TO DRIVE THE DEVELOPMENT OF MICROBIOME-BASED PRODUCTS IN INDIA
・       TABLE 121....... INDIA: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 122... INDIA: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 123.. INDIA: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.4.4            ROAPAC
・       TABLE 124... ROAPAC: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 125 ROAPAC: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 126...... ROAPAC: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)
10.5          REST OF THE WORLD (ROW)
・       TABLE 127....... ROW: HUMAN MICROBIOME MARKET, BY PRODUCT, 2019–2028 (USD MILLION)
・       TABLE 128... ROW: HUMAN MICROBIOME MARKET, BY APPLICATION, 2019–2028 (USD MILLION)
・       TABLE 129 ROW: HUMAN MICROBIOME MARKET, BY DISEASE, 2022-2028 (USD MILLION)
・       TABLE 130........ ROW: HUMAN MICROBIOME RESEARCH SPENDING MARKET, BY TECHNOLOGY,  2018–2025 (USD MILLION)
・       TABLE 131.... ROW: GENOMICS MARKET, BY TYPE, 2018–2025 (USD MILLION)
・       TABLE 132... ROW: SEQUENCING MARKET, BY METHOD, 2018–2025 (USD MILLION)

11.. COMPETITIVE LANDSCAPE

11.1          OVERVIEW
11.2          COMPANY PRODUCT FOOTPRINT
・       FIGURE 18.. PRODUCT PORTFOLIO ANALYSIS: HUMAN MICROBIOME MARKET
11.3          COMPETITIVE SCENARIO
・       TABLE 133. HUMAN MICROBIOME MARKET: DEALS, JANUARY 2020–JANUARY 2021

12.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
12.1          ENTEROME
12.2          SERES THERAPEUTICS
・       FIGURE 19...... SERES THERAPEUTICS: COMPANY SNAPSHOT (2019)
12.3          4D PHARMA PLC
・       FIGURE 20............. 4D PHARMA PLC: COMPANY SNAPSHOT (2019)
12.4          EVELO BIOSCIENCES, INC.
・       FIGURE 21. EVEL0 BIOSCIENCES, INC.: COMPANY SNAPSHOT (2019)
12.5          OPTIBIOTIX HEALTH PLC
・       FIGURE 22.... OPTIBIOTIX HEALTH PLC: COMPANY SNAPSHOT (2019)
12.6          SYNLOGIC
・       FIGURE 23..................... SYNLOGIC: COMPANY SNAPSHOT (2019)
12.7          SECOND GENOME
12.8          VEDANTA BIOSCIENCES, INC.
12.9          FERRING PHARMACEUTICALS
12.10        VITHERA PHARMACEUTICALS, INC.
12.11        BIOMX
・       FIGURE 24.......................... BIOMX: COMPANY SNAPSHOT (2019)
12.12        DUPOINT
・       FIGURE 25....................... DU PONT: COMPANY SNAPSHOT (2019)
12.13        KALEIDO
・       FIGURE 26....................... KALEIDO: COMPANY SNAPSHOT (2019)
12.14        YSOPIA BIOSCIENCE
12.15        FLIGHTPATH
12.16        FINCH THERAPEUTICS GROUP, INC
12.17        QUANTBIOME, INC. (DBA THRYVE)
12.18        VIOME, INC.
12.19        DAYTWO INC
12.20        BIOHM
12.21        ATLAS BIOMED GROUP LIMITED.
12.22        BIONE
12.23        LUXIA SCIENTIFIC
12.24        SUN GENOMICS
12.25        METABIOMICS
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13.. APPENDIX



掲載企業リスト

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。